Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
128 participants
INTERVENTIONAL
2009-01-31
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MAGGOT THERAPY & conventional therapy T
Maggot therapy,ADMINISTERED TWO TIMES AS A NEW METHODS OF DRESSING in experimental group.conventional therapy ,administered two times in control group
procedure:maggot therapy
each times in maggot therapy continued for three days.wound assessment was done before and after any intervention
conventional therapy
patients receive ordinary treatment for diabetic foot
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
procedure:maggot therapy
each times in maggot therapy continued for three days.wound assessment was done before and after any intervention
conventional therapy
patients receive ordinary treatment for diabetic foot
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The age of the patients between 40- 90 years old.
* Not having capillary disease (Blockage of artery, Rinold).
* Not user of anticoagulants and corticosteroids drugs.
* Patients without history of allergy to drugs and foods.
* Having diabetic type 2
Exclusion Criteria
* patients who have amputation
40 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kerman Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Forough Pouryazdanpanah Kermani
university instructor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
86/116
Identifier Type: -
Identifier Source: org_study_id